Literature DB >> 16923862

New insights into pulmonary inflammation in cystic fibrosis.

S Rao1, J Grigg.   

Abstract

Persistent lower airway infection with inflammation is the major cause of morbidity and mortality in cystic fibrosis. This review examines the recent advances in the understanding of airway inflammation in cystic fibrosis, and focuses on the evidence that pulmonary inflammation is, under some circumstances, disassociated from infection, and the potential implications for therapeutic intervention.

Entities:  

Mesh:

Year:  2006        PMID: 16923862      PMCID: PMC2082932          DOI: 10.1136/adc.2004.069419

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  28 in total

1.  Quantitation of inflammatory responses to bacteria in young cystic fibrosis and control patients.

Authors:  M S Muhlebach; P W Stewart; M W Leigh; T L Noah
Journal:  Am J Respir Crit Care Med       Date:  1999-07       Impact factor: 21.405

2.  Distinct pattern of immune cell population in the lung of human fetuses with cystic fibrosis.

Authors:  C Hubeau; E Puchelle; D Gaillard
Journal:  J Allergy Clin Immunol       Date:  2001-10       Impact factor: 10.793

3.  Early pulmonary infection, inflammation, and clinical outcomes in infants with cystic fibrosis.

Authors:  M Rosenfeld; R L Gibson; S McNamara; J Emerson; J L Burns; R Castile; P Hiatt; K McCoy; C B Wilson; A Inglis; A Smith; T R Martin; B W Ramsey
Journal:  Pediatr Pulmonol       Date:  2001-11

Review 4.  Inhaled corticosteroids for cystic fibrosis.

Authors:  C Dezateux; S Walters; I Balfour-Lynn
Journal:  Cochrane Database Syst Rev       Date:  2000

Review 5.  Oral non-steroidal anti-inflammatory drug therapy for cystic fibrosis.

Authors:  C Dezateux; A Crighton
Journal:  Cochrane Database Syst Rev       Date:  2000

Review 6.  Oral steroids for cystic fibrosis.

Authors:  K Cheng; D Ashby; R Smyth
Journal:  Cochrane Database Syst Rev       Date:  2000

7.  Inflammation and infection in naive human cystic fibrosis airway grafts.

Authors:  R Tirouvanziam; S de Bentzmann; C Hubeau; J Hinnrasky; J Jacquot; B Péault; E Puchelle
Journal:  Am J Respir Cell Mol Biol       Date:  2000-08       Impact factor: 6.914

8.  G551D cystic fibrosis mice exhibit abnormal regulation of inflammation in lungs and macrophages.

Authors:  G R Thomas; E A Costelloe; D P Lunn; K J Stacey; S J Delaney; R Passey; E C McGlinn; B J McMorran; A Ahadizadeh; C L Geczy; B J Wainwright; D A Hume
Journal:  J Immunol       Date:  2000-04-01       Impact factor: 5.422

9.  Inflammation, infection, and pulmonary function in infants and young children with cystic fibrosis.

Authors:  Carolyn J Dakin; Andrew H Numa; He Wang; John R Morton; Calypso C Vertzyas; Richard L Henry
Journal:  Am J Respir Crit Care Med       Date:  2002-04-01       Impact factor: 21.405

10.  Airway inflammation in children with cystic fibrosis and healthy children assessed by sputum induction.

Authors:  S D Sagel; R Kapsner; I Osberg; M K Sontag; F J Accurso
Journal:  Am J Respir Crit Care Med       Date:  2001-10-15       Impact factor: 21.405

View more
  21 in total

Review 1.  Clinical significance of microbial infection and adaptation in cystic fibrosis.

Authors:  Alan R Hauser; Manu Jain; Maskit Bar-Meir; Susanna A McColley
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

2.  Establishment and long-term culture of human cystic fibrosis endothelial cells.

Authors:  Roberto Plebani; Romina Tripaldi; Paola Lanuti; Antonio Recchiuti; Sara Patruno; Sara Di Silvestre; Pasquale Simeone; Marco Anile; Federico Venuta; Marco Prioletta; Felice Mucilli; Paola Del Porto; Marco Marchisio; Assunta Pandolfi; Mario Romano
Journal:  Lab Invest       Date:  2017-07-31       Impact factor: 5.662

3.  The role for neutrophil extracellular traps in cystic fibrosis autoimmunity.

Authors:  Sladjana Skopelja; B JoNell Hamilton; Jonathan D Jones; Mei-Ling Yang; Mark Mamula; Alix Ashare; Alex H Gifford; William Fc Rigby
Journal:  JCI Insight       Date:  2016-10-20

4.  Kinase suppressor of Ras-1 protects against pulmonary Pseudomonas aeruginosa infections.

Authors:  Yang Zhang; Xiang Li; Alexander Carpinteiro; Jeremy A Goettel; Matthias Soddemann; Erich Gulbins
Journal:  Nat Med       Date:  2011-02-06       Impact factor: 53.440

5.  Pseudomonas aeruginosa defense systems against microbicidal oxidants.

Authors:  Bastian Groitl; Jan-Ulrik Dahl; Jeremy W Schroeder; Ursula Jakob
Journal:  Mol Microbiol       Date:  2017-08-29       Impact factor: 3.501

6.  Antipseudomonal Bacteriophage Reduces Infective Burden and Inflammatory Response in Murine Lung.

Authors:  Rishi Pabary; Charanjit Singh; Sandra Morales; Andrew Bush; Khalid Alshafi; Diana Bilton; Eric W F W Alton; Anthony Smithyman; Jane C Davies
Journal:  Antimicrob Agents Chemother       Date:  2015-11-16       Impact factor: 5.191

7.  Eicosanoid release is increased by membrane destabilization and CFTR inhibition in Calu-3 cells.

Authors:  Florence Borot; Diane-Lore Vieu; Grazyna Faure; Janine Fritsch; Julien Colas; Sandra Moriceau; Maryvonne Baudouin-Legros; Franck Brouillard; Jesus Ayala-Sanmartin; Lhousseine Touqui; Marc Chanson; Aleksander Edelman; Mario Ollero
Journal:  PLoS One       Date:  2009-10-22       Impact factor: 3.240

Review 8.  Lessons learned from the cystic fibrosis pig.

Authors:  David K Meyerholz
Journal:  Theriogenology       Date:  2016-04-21       Impact factor: 2.740

9.  Potential role of high-mobility group box 1 in cystic fibrosis airway disease.

Authors:  Steven M Rowe; Patricia L Jackson; Gang Liu; Mathew Hardison; Alessandra Livraghi; G Martin Solomon; D Brent McQuaid; Brett D Noerager; Amit Gaggar; J P Clancy; Wanda O'Neal; Eric J Sorscher; Edward Abraham; J Edwin Blalock
Journal:  Am J Respir Crit Care Med       Date:  2008-07-24       Impact factor: 21.405

10.  Novel experimental Pseudomonas aeruginosa lung infection model mimicking long-term host-pathogen interactions in cystic fibrosis.

Authors:  Claus Moser; Maria Van Gennip; Thomas Bjarnsholt; Peter Østrup Jensen; Baoleri Lee; Hans Petter Hougen; Henrik Calum; Oana Ciofu; Michael Givskov; Søren Molin; Niels Høiby
Journal:  APMIS       Date:  2009-02       Impact factor: 3.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.